Beyond Estrogen: Targeting Gonadotropin Hormones in the Treatment of Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|3|4|281-285

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.3, Iss.4, 2004-08, pp. : 281-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Estrogen Myth: Potential Use of Gonadotropin-Releasing Hormone Agonists for the Treatment of Alzheimer's Disease

By Casadesus Gemma  

Drugs in R&D, Vol. 7, Iss. 3, 2006-01 ,pp. : 187-193

Adis International

Access to resources Recommend Favorite

Targeting Insulin Signaling for the Treatment of Alzheimer's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-02 ,pp. : 485-492

Bentham Science Publishers

Access to resources Recommend Favorite

Estrogen and Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1351, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Targeting Human Astrocytes' Calcium-sensing Receptors for Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 4990-5000

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond Tacrine: Recently Developed Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease

By Unni L.K.  

CNS Drugs, Vol. 10, Iss. 6, 1998-12 ,pp. : 447-460

Adis International

Access to resources Recommend Favorite